CHA Biotech Co. Ltd Total Liabilities

Latest as of June 2026: ₩1.83 Trillion KRW ≈ $1.24 Billion USD

CHA Biotech Co. Ltd total liabilities. Based on the latest financial reports, CHA Biotech Co. Ltd (085660) has total liabilities worth ₩1.83 Trillion KRW (≈ $1.24 Billion USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check CHA Biotech Co. Ltd liquid asset ratio to evaluate the company's liquid asset resilience ratio.

Total Liabilities of CHA Biotech Co. Ltd (2008–2025)

Total liabilities of CHA Biotech Co. Ltd from 2008 to 2025. This chart illustrates how CHA Biotech Co. Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore CHA Biotech Co. Ltd long-term investment intensity to see how much of total assets are deployed in long-term investments.

CHA Biotech Co. Ltd Competitors by Total Liabilities

The table below lists competitors of CHA Biotech Co. Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Trade-Van Information Services Co TW:6183	Taiwan	NT$1.78 Billion
Napatech A/S OL:NAPA	Norway	Nkr59.29 Million
Daou Data Corp KQ:032190	Korea	₩67.26 Trillion
Bannari Amman Sugars Limited NSE:BANARISUG	India	Rs2.44 Billion
Sichuan Etrol Technologies Co Ltd SHE:300370	China	CN¥779.86 Million
Kumyang KO:001570	Korea	₩750.35 Billion
Apex International Co Ltd TW:4927	Taiwan	NT$13.95 Billion
Leo Lithium Ltd AU:LLL	Australia	AU$12.06 Million

Liability Composition Analysis (2008–2025)

This chart breaks down CHA Biotech Co. Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see CHA Biotech Co. Ltd (085660) total assets.

Liquidity & Leverage Metrics

CHA Biotech Co. Ltd Total Liabilities Ratios Explained

CHA Biotech Co. Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric	Value	Description
Current Ratio	0.89	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	4.41	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.64	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how CHA Biotech Co. Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for CHA Biotech Co. Ltd (2008–2025)

The table below shows the annual total liabilities of CHA Biotech Co. Ltd from 2008 to 2025.

Year	Total Liabilities	Change
2025-12-31	₩1.74 Trillion ≈ $1.18 Billion	-8.97%
2024-12-31	₩1.91 Trillion ≈ $1.29 Billion	+78.60%
2023-12-31	₩1.07 Trillion ≈ $724.61 Million	-18.71%
2022-12-31	₩1.32 Trillion ≈ $891.34 Million	+21.89%
2021-12-31	₩1.08 Trillion ≈ $731.27 Million	+12.57%
2020-12-31	₩958.62 Billion ≈ $649.64 Million	+22.00%
2019-12-31	₩785.74 Billion ≈ $532.48 Million	+26.62%
2018-12-31	₩620.54 Billion ≈ $420.53 Million	+10.25%
2017-12-31	₩562.87 Billion ≈ $381.45 Million	+16.63%
2016-12-31	₩482.61 Billion ≈ $327.06 Million	+36.05%
2015-12-31	₩354.73 Billion ≈ $240.39 Million	+93.39%
2014-12-31	₩183.43 Billion ≈ $124.31 Million	+5.96%
2013-12-31	₩173.12 Billion ≈ $117.32 Million	-7.45%
2012-12-31	₩187.06 Billion ≈ $126.76 Million	-1.32%
2011-12-31	₩189.56 Billion ≈ $128.46 Million	+7.67%
2010-12-31	₩176.06 Billion ≈ $119.32 Million	+71.36%
2009-12-31	₩102.75 Billion ≈ $69.63 Million	+402.00%
2008-12-31	₩20.47 Billion ≈ $13.87 Million	--

About CHA Biotech Co. Ltd

KQ:085660 Korea Biotechnology

Market Cap

$428.43 Million

₩632.19 Billion KRW

Market Cap Rank

#12736 Global

#360 in Korea

Share Price

₩6800.00

Change (1 day)

+0.74%

52-Week Range

₩6750.00 - ₩23850.00

All Time High

₩40950.00